Despite improvements in neuroblastoma treatment, survival figures lag behind those of many other childhood malignancies. New ...
Journal of Nuclear Medicine February 2025, jnumed.124.268079; DOI: https://doi.org/10.2967/jnumed.124.268079 ...
Journal of Nuclear Medicine February 2025, jnumed.124.269024; DOI: https://doi.org/10.2967/jnumed.124.269024 ...
Journal of Nuclear Medicine February 2025, jnumed.124.267855; DOI: https://doi.org/10.2967/jnumed.124.267855 ...
Journal of Nuclear Medicine February 2025, jnumed.124.269401; DOI: https://doi.org/10.2967/jnumed.124.269401 ...
Journal of Nuclear Medicine February 2025, jnumed.124.267809; DOI: https://doi.org/10.2967/jnumed.124.267809 ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Radiopharmaceutical therapy (RPT), with its targeted delivery of cytotoxic ionizing radiation, demonstrates significant potential for treating a wide spectrum of malignancies, with particularly unique ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Reply: A Comment on “Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study” ...
Between June 2013 and April 2018, datasets from 7,013 patients with PSMA PET for PCa were retrospectively reviewed at 6 high-volume nuclear medicine centers, and 16 patients with PSA persistence after ...
S.J. McPhee, M.A. Papadakis, and L.M. Tierney, Jr., eds. New York, NY: McGraw Hill Medical, 2008, 1,673 pages, $69.95 Medicine is an ever-changing field, and changes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results